Literature DB >> 33068617

Association of Severity of Dry Eye Disease with Work Productivity and Activity Impairment in the Dry Eye Assessment and Management Study.

Giampaolo Greco1, Maxwell Pistilli2, Penny A Asbell3, Maureen G Maguire4.   

Abstract

PURPOSE: To evaluate the association of dry eye disease (DED) severity with work productivity and activity impairment.
DESIGN: Longitudinal, observational study within a randomized clinical trial. PARTICIPANTS: People with moderate to severe DED who enrolled in the multicenter Dry Eye Assessment and Management (DREAM) study.
METHODS: Participants completed the Work Productivity and Activity Impairment questionnaire at 0, 6, and 12 months and were assessed in parallel for symptoms and signs (conjunctival and corneal staining, tear film break-up time [TBUT], and Schirmer test) of DED. Associations of work productivity and activity impairment with symptom and signs were evaluated with linear regression models using generalized estimating equations and controlling for demographics and comorbidities. MAIN OUTCOME MEASURES: Work productivity (employment, absenteeism, presenteeism, overall work impairment) and activity impairment.
RESULTS: Among 535 participants at baseline, 279 (52%) were employed, and mean activity impairment was 24.5%. Among those employed, the mean score was 2% for absenteeism, 18% for presenteeism, and 19.6% for overall work impairment. Higher Ocular Surface Disease Index (OSDI) symptom scores were associated with greater absenteeism, presenteeism, and activity impairment. Overall work impairment and activity impairment were greater by 4.3% and 4.8%, respectively, per 10-unit difference in OSDI score (P < 0.001). Longitudinal increases (worsening) in OSDI scores were associated with increasing impairment in work and non-work-related activity: 2.0% and 3.1% per 10 units in OSDI, respectively (P < 0.01). Worse corneal staining and TBUT were associated with higher overall work impairment and activity level (P ≤ 0.04). However, longitudinal changes in these two signs were not associated with changes in work productivity or activity impairment.
CONCLUSIONS: Worse symptoms of DED are associated with decreased work productivity and activity level, both cross-sectionally (interindividually) and longitudinally within person (intraindividually). Corneal staining and TBUT are associated with interindividual differences but not intraindividual changes in work productivity and activity impairment.
Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dry eye disease; Economic impact; Work productivity

Mesh:

Year:  2020        PMID: 33068617      PMCID: PMC8046838          DOI: 10.1016/j.ophtha.2020.10.015

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   14.277


  17 in total

1.  The validity and reproducibility of a work productivity and activity impairment instrument.

Authors:  M C Reilly; A S Zbrozek; E M Dukes
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

2.  Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics.

Authors:  Penny A Asbell; Maureen G Maguire; Ellen Peskin; Vatinee Y Bunya; Eric J Kuklinski
Journal:  Contemp Clin Trials       Date:  2018-06-06       Impact factor: 2.226

Review 3.  TFOS DEWS II Epidemiology Report.

Authors:  Fiona Stapleton; Monica Alves; Vatinee Y Bunya; Isabelle Jalbert; Kaevalin Lekhanont; Florence Malet; Kyung-Sun Na; Debra Schaumberg; Miki Uchino; Jelle Vehof; Eloy Viso; Susan Vitale; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

4.  Reliability and validity of the Ocular Surface Disease Index.

Authors:  R M Schiffman; M D Christianson; G Jacobsen; J D Hirsch; B L Reis
Journal:  Arch Ophthalmol       Date:  2000-05

5.  Estimated Prevalence and Incidence of Dry Eye Disease Based on Coding Analysis of a Large, All-age United States Health Care System.

Authors:  Reza Dana; John L Bradley; Annie Guerin; Irina Pivneva; Ipek Özer Stillman; Amber M Evans; Debra A Schaumberg
Journal:  Am J Ophthalmol       Date:  2019-02-02       Impact factor: 5.258

6.  Dry Eye Disease: Impact on Quality of Life and Vision.

Authors:  Miki Uchino; Debra A Schaumberg
Journal:  Curr Ophthalmol Rep       Date:  2013-06

Review 7.  The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research.

Authors:  Stephen C Pflugfelder; Cintia S de Paiva
Journal:  Ophthalmology       Date:  2017-11       Impact factor: 12.079

8.  Dry eye disease and work productivity loss in visual display users: the Osaka study.

Authors:  Miki Uchino; Yuichi Uchino; Murat Dogru; Motoko Kawashima; Norihiko Yokoi; Aoi Komuro; Yukiko Sonomura; Hiroaki Kato; Shigeru Kinoshita; Debra A Schaumberg; Kazuo Tsubota
Journal:  Am J Ophthalmol       Date:  2013-11-01       Impact factor: 5.258

9.  Relationship between dry eye symptoms and pain sensitivity.

Authors:  Jelle Vehof; Diana Kozareva; Pirro G Hysi; Juliette Harris; Ayrun Nessa; Frances K Williams; David L H Bennett; Steve B McMahon; Samantha J Fahy; Kenan Direk; Tim D Spector; Christopher J Hammond
Journal:  JAMA Ophthalmol       Date:  2013-10       Impact factor: 7.389

10.  Impact of dry eye on work productivity.

Authors:  Masakazu Yamada; Yoshinobu Mizuno; Chika Shigeyasu
Journal:  Clinicoecon Outcomes Res       Date:  2012-10-10
View more
  4 in total

Review 1.  Transgenic dry eye mouse models: powerful tools to study dry eye disease.

Authors:  Dan-Yi Qin; Li-Xiang Wang; Ying-Ping Deng
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

2.  Meibomian gland atrophy with duration of Sjogren's syndrome in adult females.

Authors:  Sung Rae Noh; Jae Lim Chung; Jeong Min Lee; Kyoung Yul Seo; Kyungmin Koh
Journal:  Int Ophthalmol       Date:  2021-08-19       Impact factor: 2.031

3.  Assessing the Quality, Reliability, and Readability of Online Information on Dry Eye Disease.

Authors:  Marko Oydanich; Eric Kuklinski; Penny A Asbell
Journal:  Cornea       Date:  2022-03-24       Impact factor: 3.152

4.  Long Non-coding RNAs Gabarapl2 and Chrnb2 Positively Regulate Inflammatory Signaling in a Mouse Model of Dry Eye.

Authors:  Yuhan Yang; Minjie Chen; Zimeng Zhai; Yiqin Dai; Hao Gu; Xujiao Zhou; Jiaxu Hong
Journal:  Front Med (Lausanne)       Date:  2021-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.